Category: PRESS RELEASES

Vectara now available with LangChain

Vectara and LangChain announce integration of Vectara state-of-the-art retrieval engine with LangChain’s flexible open-source framework for building LLM-powered applications SANTA CLARA, Calif., June 06, 2023 (GLOBE NEWSWIRE) — Vectara, the Generative AI (GenAI) conversational search platform, announces its integration with LangChain, a leading open-source project for building LLM-powered applications. With

Read More....

Madison Realty Capital Originates $262 Million Construction Loan for E11EVEN Residences Beyond Luxury Condominiums in Miami

NEW YORK, June 06, 2023 (GLOBE NEWSWIRE) — Madison Realty Capital, a vertically integrated real estate private equity firm focused on debt and equity investment strategies, today announced it has originated a $262 million construction loan to developers PMG and E11EVEN Partners for E11EVEN Residences Beyond, an ultra-luxury, dual-tower development located in Miami’s

Read More....

Getinge Selects Anaqua to Provide Single, Centralized IP Management Platform

Global medical technology company will use Anaqua’s AQX to help consolidate and coordinate the management of all its IP assets BOSTON, June 06, 2023 (GLOBE NEWSWIRE) — Anaqua, the leading innovation and intellectual property (IP) management technology provider, today announced that global medical technology company Getinge has selected Anaqua’s AQX in order

Read More....

Telesis Bio to Present at Antibody Engineering and Therapeutics, Europe 2023

Showcasing full suite of molecular biology workflow solutions for streamlining antibody discovery SAN DIEGO, June 06, 2023 (GLOBE NEWSWIRE) — Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced they will be showcasing their automated workflow solutions for streamlining discovery workflows in antibody

Read More....

Telesis Bio Announces Closing of $28.0 Million Private Placement of Preferred Stock And Warrants to Purchase an Additional $46.2 Million of Common Stock

SAN DIEGO, June 05, 2023 (GLOBE NEWSWIRE) — Telesis Bio Inc. (NASDAQ: TBIO), a leader in molecular biology automation solutions for multi-omic and synthetic biology applications, today announced the closing of its private placement of redeemable convertible preferred stock and warrants resulting in initial gross proceeds of $28.0 million to

Read More....

UPDATE — VERSES, DENTONS US and SWF, Announce Collaboration on Landmark Industry Report “A Path to Global AI Governance”

Figure 1 VANCOUVER, British Columbia, June 05, 2023 (GLOBE NEWSWIRE) — VERSES AI Inc. (CBOE CANADA:VERS) (OTCQX:VRSSF) (“VERSES” or the “Company”), a cognitive computing company specializing in the next generation of artificial intelligence (“AI”), announces the release in June 2023 of an AI industry report titled “THE ROAD TO AUTONOMY:

Read More....